| Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation MM Caffarel, D Sarrió, J Palacios, M Guzmán, C Sánchez Cancer research 66 (13), 6615-6621, 2006 | 284 | 2006 |
| New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies E Larrea, C Sole, L Manterola, I Goicoechea, M Armesto, M Arestin, ... International journal of molecular sciences 17 (5), 627, 2016 | 262 | 2016 |
| Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition MM Caffarel, C Andradas, E Mira, E Pérez-Gómez, C Cerutti, ... Molecular cancer 9, 1-11, 2010 | 232 | 2010 |
| The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK C Andradas, MM Caffarel, E Pérez-Gómez, M Salazar, M Lorente, ... Oncogene 30 (2), 245-252, 2011 | 220 | 2011 |
| Cannabinoids: a new hope for breast cancer therapy? MM Caffarel, C Andradas, E Pérez-Gómez, M Guzmán, C Sánchez Cancer treatment reviews 38 (7), 911-918, 2012 | 149 | 2012 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ... Journal of Biological Chemistry 289 (32), 21960-21972, 2014 | 134 | 2014 |
| Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel, ... Journal of the National Cancer Institute 107 (6), djv077, 2015 | 119 | 2015 |
| A multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology JJ Campbell, N Davidenko, MM Caffarel, RE Cameron, CJ Watson PloS one 6 (9), e25661, 2011 | 110 | 2011 |
| JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells MM Caffarel, G Moreno-Bueno, C Cerutti, J Palacios, M Guzman, ... Oncogene 27 (37), 5033-5044, 2008 | 95 | 2008 |
| Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma MM Caffarel, N Coleman The Journal of pathology 232 (4), 386-390, 2014 | 86 | 2014 |
| Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer S Blasco-Benito, E Moreno, M Seijo-Vila, I Tundidor, C Andradas, ... Proceedings of the National Academy of Sciences 116 (9), 3863-3872, 2019 | 60 | 2019 |
| The role of the il-6 cytokine family in epithelial–mesenchymal plasticity in cancer progression A Abaurrea, AM Araujo, MM Caffarel International journal of molecular sciences 22 (15), 8334, 2021 | 53 | 2021 |
| Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state JE Hanning, HK Saini, MJ Murray, MM Caffarel, S van Dongen, D Ward, ... The Journal of pathology 231 (3), 354-366, 2013 | 46 | 2013 |
| Over-expression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival JA Kucia-Tran, V Tulkki, S Smith, CG Scarpini, K Hughes, AM Araujo, ... British Journal of Cancer, 2016 | 44 | 2016 |
| Tissue transglutaminase mediates the pro‐malignant effects of oncostatin M receptor over‐expression in cervical squamous cell carcinoma MM Caffarel, A Chattopadhyay, AM Araujo, J Bauer, CG Scarpini, ... The Journal of Pathology 231 (2), 168-179, 2013 | 44 | 2013 |
| Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis MM Caffarel, R Zaragoza, S Pensa, J Li, AR Green, CJ Watson Cell Death & Differentiation 19 (3), 511-522, 2012 | 37 | 2012 |
| Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein EJ Gauson, B Windle, MM Donaldson, MM Caffarel, ES Dornan, ... Virology 468, 10-18, 2014 | 35 | 2014 |
| Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment AM Araujo, A Abaurrea, P Azcoaga, JI López-Velazco, S Manzano, ... The Journal of clinical investigation 132 (7), 2022 | 32 | 2022 |
| Anti‐oncostatin M antibody inhibits the pro‐malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma JA Kucia‐Tran, V Tulkki, CG Scarpini, S Smith, M Wallberg, ... The Journal of Pathology 244 (3), 283-295, 2018 | 28 | 2018 |
| Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) from other renal neoplasms CH Lawrie, M Armesto, M Fernandez-Mercado, M Arestín, L Manterola, ... The Journal of Molecular Diagnostics 20 (1), 34-45, 2018 | 24 | 2018 |
CRISTINA SANCHEZComplutense UniversityVerified email at quim.ucm.es
